How many investments has Iter Investments made?

Iter Investments has 26 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.

What stage does Iter Investments invest at?

Iter Investments invests at the Seed, Series A, Series B stages.

What sectors does Iter Investments focus on?

Iter Investments focuses on Healthtech, Mental Health, Wellness & Fitness.

Where is Iter Investments located?

Iter Investments is headquartered in South Florida, US.

Who does Iter Investments co-invest with?

Iter Investments most often shares deals with PsyMed Ventures, Beni Venture Capital, Bonaventure Equity, LLC, among 24 tracked co-investors.

Iter Investments

Venture capital

South Florida · Seed–Series B · 15 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

✨ Fox Verdict

Investment thesis

Iter Investments targets the alternative therapeutics industry with a focus on breakthrough companies advancing mental and behavioral health innovations. The firm brings together a multidisciplinary team of investors, scientists, physicians, and technologists to support entrepreneurs building companies with the potential to revolutionize mental health and well-being globally.

Invests inHealthtech Mental Health Wellness & Fitness Fort Lauderdale Global

Source: firm website, verified Aug 5, 2026.

Stage

Seed–Series B

South Florida, FL, US

Instruments

Equity

Founded

2020

Last 12 months

1 investment

Tracked investments

Team · 15 people

from the firm's website & public directories

Dustin Robinson, Esq. CPA· Founder

Attorney and CPA specializing in cannabis and psychedelic regulatory matters, ranked among the top 100 most influential people in psychedelics. Founder of a leading non-profit advancing psychedelic legalization, with extensive expertise in highly regulated industries.

Robert Velarde· Founder

Seasoned private equity investor with over 25 years of global experience across multiple industries and geographies. Experienced in building and managing private markets platforms within institutional, family office, and impact investment contexts.

Dustin Robinson· Managing Director· Fort Lauderdale, Floridain

Dustin Robinson is a Managing Principal at Iter Investments, an investment firm focused on brain health technologies and treatments. Licensed as an attorney and CPA, Robinson founded multiple ventures including LumaLex Law, a law firm serving emerging industries; Nucleus, a venture studio in the psychedelic sector; Mr. Cannabis Law and Mr. Psychedelic Law consulting practices; and Infinite Wellness, a medical marijuana treatment center in Florida.

Roberto Velarde· Managing Partner· United Statesin

Roberto Velarde is Managing Partner at Iter Investments. He has over 25 years of private equity investment experience across multiple regions including the US, Latin America, Europe, and Asia, spanning various industries. He has previously built and managed private markets investment platforms at institutional, family office, and impact investment firms.

Amanda Barton· Legal Advisor

Florida-licensed attorney with over a decade of experience in corporate matters, governance, finance, and regulatory compliance. Specializes in transactional business law.

Andrew Hall, PhD· Scientific Lead

Chief scientific officer focused on standardization of cultivation, extraction, and testing of medicinal plants. Expertise spans laboratory startup, method development, and federal compliance requirements.

David Wood, Esq. PhD· Intellectual Property Lead

Chief legal officer and general counsel for psychedelic firms, specializing in intellectual property, regulatory issues, and patent law in the psychedelic industry.

Dr. Michelle Weiner, DO MPH· Clinical Lead

Board-certified physician specializing in physical medicine, rehabilitation, and pain management. Investigates cannabis alternatives for opioid substitution and pain in seniors, serving as chair of Florida's Medical Marijuana Advisory Committee.

Dr. Scott Fisher, MD· Psychiatric Lead

Psychiatrist with certification in psychedelic therapy and research. Leads FDA Phase 2 clinical trial assessing psilocybin efficacy for severe depression.

Edgar Asebey, Esq· FDA Lead

FDA regulatory and transactional attorney advising life sciences, cannabis, and psychedelic ventures. Former patent advisor at the National Cancer Institute and former founder and CEO of pharmaceutical company Andes Pharmaceuticals.

John M.H. Gregg, MBA, CLP· Commercialization Lead

Biotech and pharmaceutical executive with extensive experience in clinical development and commercialization of infectious disease, anti-infective, and oncology products. Currently CEO of BalinBac Therapeutics.

Rayyan Zafar· Research Lead

PhD researcher in neuropsychopharmacology at Imperial College London under Professor David Nutt, conducting research on addiction mechanisms and novel pharmacological interventions including psychedelics for psychiatric conditions.

Samuel Baum· Marketing Lead

Marketing expert with over 20 years of experience spanning international strategy and grassroots campaigns. Founder of Launch Sequence Agency and former director of marketing at Red Bull.

Andrew Hall· Scientific Lead· Fort Lauderdale, Floridain

Andrew Hall holds a Ph.D. in Natural Products and is founder of Dr Halls. He has extensive experience developing and launching medical devices, pharmaceuticals, nutraceuticals, and natural products, with particular expertise in operations scaling, regulatory compliance, and fundraising from venture capital and private equity sources. His background includes building Green Scientific Labs from 3 to 80 employees and obtaining ISO accreditations that resulted in one of Florida's largest cannabis testing facilities, as well as launching Physicians Lab, a clinical diagnostic testing facility focused on hormone and anti-aging testing.

Matt Savarick· Tech Lead· Boca Raton, Floridain

Healthcare technology executive with experience scaling mental health startups and leading business development at major medical device manufacturer. Holds degrees in neuroscience and management.

What they invest in

from 15 of 26 portfolio companies

Mental Health ×12Biotech ×8Digital Health ×8Healthtech ×5Wellness & Fitness ×5AI & Machine Learning ×3AgTech ×1Consumer ×1

HQs:United States×5Canada×1

Investments · 26 tracked

founders shown can be your intro path

By year:2026 · 1 2021 · 34 dated

aNUma

Apex Labsapexlabs.com in 𝕏

APEX Labs is a pharmaceutical company developing, clinically evaluating, and commercializing psilocybin-based therapies for depression and PTSD, with a primary focus on veteran populations.

BiotechDigital HealthMental Health

Awakn Life Sciences

Toronto

Benjamin Sessa(Executive Officer, Director)Shaun McNully(Executive Officer)Anthony Tennyson(Executive Officer, Director)Jonathan Held(Executive Officer, Director)George Scorsis(Director)James Collins(Executive Officer)

Awkn Life Sciences Incawaknlifesciences.com inacquired by Solvonis Therapeutics

BiotechDigital HealthMental Health

Co-investorsJLS

Beckley Psytechbeckleypsytech.com

AtaiBeckley develops rapid-acting and durable mental health treatments for patients with difficult-to-treat mental health conditions.

BiotechMedical DevicesMental Health

Christian AngermayerSrinivas Rao

Co-investorsFJ Labs Leafy Tunnel Noetic Redbus Ventures What If Ventures

Beckley Retreatsbeckleyretreats.com inFeb 2026

Beckley Retreats operates research-informed, legal psilocybin retreat programs, combining pre-retreat preparation, guided psilocybin sessions, and post-retreat integration for individuals seeking personal growth and greater connection.

Mental HealthTravel & HospitalityWellness & FitnessFrederick, US

Neil Markey(Executive Officer, Director)AZA Allsop(Head of Research)Rock Feilding-Mellen(Director)

Clairvoyant

Clairvoyantrxclairvoyantrx.com

Fluence

Fluencetrainingfluencetraining.com in

Fluence provides education and professional certification in psychedelic therapy for therapists and mental health professionals, offering courses on molecule-specific treatments (MDMA, psilocybin, ketamine), harm reduction, and integration.

Digital HealthEdTechMental Health

Co-investorsJLS

Freedom Bio

Freedom Biosciencesfreedombio.co in 𝕏

Freedom Biosciences develops neuropsychiatric therapeutics, focusing on novel treatments for conditions including depression, PTSD, and alcoholism.

BiotechDigital HealthMental Health

Dr. John Krystal(Co-founder & CEO)inDina Burkitbayeva(Co-founder)in

Co-investorsBeni Venture Capital LongeVC Manta Ray Ventures PsyMed Ventures Unruly Capital MBX Capital

Interaxonchoosemuse.com in 𝕏

Muse is a brain-sensing wearable platform that combines EEG and fNIRS technology to help users improve sleep, manage stress, and enhance cognitive performance through real-time neurofeedback.

AI & Machine LearningConsumerHardwareHealthtechWellness & FitnessToronto

Ariel Garten(Co-founder and Chief Evangelism Officer)Chris Aimone(Co-founder and Chief Innovation Officer)Trevor Coleman(Executive Officer, Director)Derek Luke(Executive Officer)

BoardJason Wong(Director)Sid Paquette(Director)

Co-investorsInnovative Solutions Canada New Ground Ventures OMERS Ventures

MAPS

Muse

Nucleuswithnucleus.com

Nucleus is a venture studio that launches, acquires, and partners with brands and technologies focused on mental wellness and the psychedelic medicine industry.

Digital HealthMental HealthWellness & Fitness

Nucleus Holding

Psilerapsilera.comJul 2021

Psilera is a biotech company developing neuroscience-focused therapeutics, including its lead asset PSIL-006, described as next-generation mindful medicine.

AI & Machine LearningBiotechDeep TechHealthtechMental HealthTampa, US

Jacqueline Lee Salm(Executive Officer)Jackie von Salm(Co-Founder & Chief Scientific Officer)inChris Witowski(Co-Founder & CEO)Scott Rairigh(EVP, Corporate Development)Magali Haas(Chief Medical Officer)

Co-investorsBonaventure Equity, LLC

Psygenpsygen.ca in 𝕏

Psygen is a contract development and manufacturing organization (CDMO) producing psychedelic and neuroplastogen active pharmaceutical ingredients such as LSD, MDMA, and psilocybin, and offering CMC services.

BiotechHealthtechMental Health

Co-investorsNoetic

PsyTech

Psytechglobalpsytechglobal.com

Psytech Global publishes psychedelic research articles and magic mushroom strain guides written by a team of physicians and experts.

Media & EntertainmentWellness & Fitness

Quantified Citizenquantifiedcitizen.com in 𝕏

Quantified Citizen is a mobile health-studies and lifelog app that lets users track health factors such as anxiety, stress, depression, and sleep quality using scientifically-validated scales, or join research studies on topics like mental health and psychedelic therapy.

Digital HealthHealthtechMental Health

Reset Pharmaresetpharma.com in 𝕏Nov 2021

Reset Pharma is a CNS-focused pharmaceutical company developing psilocybin and related psychedelics for the treatment of mental illness in patients with life-threatening diseases.

BiotechDigital HealthHealthtechMental HealthNew York, US

John Andreadis(Executive Officer, Director)Jan-Anders Karlsson(Executive Officer, Director)Philip Taub(Director)Tim Schlidt(Director)

Co-investorsPsyMed Ventures

Sensorium Therapeuticssensorium.bio inJul 2021

Sensorium Therapeutics is a clinical-stage biotech company developing novel CNS therapies for anxiety, epilepsy, and cognitive dysfunction using its SensAI platform, which integrates AI, chemistry, and curated natural product data to identify therapeutic patterns from over 50 million biological relationships.

AI & Machine LearningBiotechDigital HealthMedford, US

Jerrold Rosenbaum(Director)inJacob Hooker(Executive Officer, Director)inPranav Tadi(Executive Officer)

BoardRyan Katz(Director)inKevin Lalande(Director)inRichard Simon(Director)

Co-investorsBonaventure Equity, LLC Hatteras Venture Partners Mission Biocapital Service Provider Capital Route 66 Ventures Sante Health Ventures

Tripptripp.com in 𝕏

TRIPP provides immersive meditation and mindfulness experiences available through a mobile app and VR headset platform.

AgTechMental HealthWellness & FitnessVenice, US

Nanea Reeves(Executive Officer, Director)inZachary Norman(Executive Officer, Director)Kevin Keeland(Executive Officer)

BoardTim Chang(Director)

Co-investorsBeni Venture Capital Bitkraft Esports Ventures Grit Capital Partners Hartmann Capital Mayfield Fund Presence Capital +3 more

Wesana

Exits · 1

IPOs and acquisitions across the tracked portfolio

Awkn Life Sciences Incacq. by Solvonis Therapeutics

Portfolio news

latest coverage across their companies

Lilly enters psychedelic drug race with up to $3.8 billion AtaiBeckley deal | 1470 & 100.3 WMBD

Beckley Psytech · wmbdradio.com · Jul 16, 2026

Konstantin Sokolov to lead Tripp+ enterprise fund - ARMENPRESS Armenian News Agency

Tripp · armenpress.am · Jul 15, 2026

Sensorium Therapeutics Raises $25M in Series A Funding

Sensorium Therapeutics · finsmes.com · Aug 29, 2025

Frequently asked questions

How many investments has Iter Investments made?: Iter Investments has 26 tracked investments, 1 of which have exited via acquisition or IPO, including 1 dated in the last 24 months.
What stage does Iter Investments invest at?: Iter Investments invests at the Seed, Series A, Series B stages.
What sectors does Iter Investments focus on?: Iter Investments focuses on Healthtech, Mental Health, Wellness & Fitness.
Where is Iter Investments located?: Iter Investments is headquartered in South Florida, US.
Who does Iter Investments co-invest with?: Iter Investments most often shares deals with PsyMed Ventures, Beni Venture Capital, Bonaventure Equity, LLC, among 24 tracked co-investors.

Media · Podcasts & interviews

featuring the team

r/shroomstocks - Host Dustin Robinson of Iter Investments is joined in conversation by the Founder and CEO of Adamo Bioscience, Dr. Molly Maloof. While in the hot seat, Dr. Molly answers tough questions that every investor should know about Adamo Bioscience. Airs live June/23/2020 (Today) @ 4pm est.

Dustin Robinson · reddit.com

TIME TO INVEST IN Psychedelic Stocks | Iter Investments Founder Dustin Robinson Explains Why!

InvestorPlace · Dustin Robinson

Images

Similar investors

JAZZ Venture Partners

JAZZ Venture Partners is a venture capital firm investing in companies at the intersection of technology, neuroscience, and human performance, spanning digital health, biosciences, and AI.

$100K – $20M

Equitage Ventures, L.L.C.

Equitage Ventures is an early-stage investor providing capital, distribution, and strategic guidance to entrepreneurs addressing the physical, mental, spiritual, and social needs of older adults across the senior care continuum.

$250K – $2.5M

HealthQuad

HealthQuad is a healthcare-focused investment firm that partners with entrepreneurs building category-defining healthcare businesses, leveraging its healthcare network and clinical/operating expertise.

Wisdom Ventures

Wisdom Ventures is a venture capital firm that invests in entrepreneurs building tech-enabled wellbeing companies focused on wisdom, mindfulness, and human connection.

Foreground Capital

Foreground Capital is a venture capital firm dedicated to investing in the future of women's health, building on its predecessor track record at RH Capital.